Carleton BC - Search Results

1

Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children.

Visscher H, Ross CJ, Rassekh SR, Sandor GS, Caron HN, van Dalen EC, Kremer LC, van der Pal HJ, Rogers PC, Rieder MJ, Carleton BC, Hayden MR; CPNDS Consortium. Visscher H, et al. Among authors: carleton bc. Pediatr Blood Cancer. 2013 Aug;60(8):1375-81. doi: 10.1002/pbc.24505. Epub 2013 Feb 25. Pediatr Blood Cancer. 2013. PMID: 23441093 Clinical Trial.

2

Pharmacogenomics and its implications for autoimmune disease.

Ross CJ, Katzov H, Carleton B, Hayden MR. Ross CJ, et al. J Autoimmun. 2007 Mar-May;28(2-3):122-8. doi: 10.1016/j.jaut.2007.02.008. Epub 2007 Apr 5. J Autoimmun. 2007. PMID: 17418528

3

Genotypic approaches to therapy in children: a national active surveillance network (GATC) to study the pharmacogenomics of severe adverse drug reactions in children.

Ross CJ, Carleton B, Warn DG, Stenton SB, Rassekh SR, Hayden MR. Ross CJ, et al. Ann N Y Acad Sci. 2007 Sep;1110:177-92. doi: 10.1196/annals.1423.020. Ann N Y Acad Sci. 2007. PMID: 17911433

4

Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study.

Madadi P, Ross CJ, Hayden MR, Carleton BC, Gaedigk A, Leeder JS, Koren G. Madadi P, et al. Among authors: carleton bc. Clin Pharmacol Ther. 2009 Jan;85(1):31-5. doi: 10.1038/clpt.2008.157. Epub 2008 Aug 20. Clin Pharmacol Ther. 2009. PMID: 18719619

5

Genotypic Approaches to Therapy in Children (GATC): using information technology to improve drug safety.

Wong E, Carleton BC, Wright DF, Smith MA, Verbeek L, Hildebrand CA, Stannard P, Vaillancourt R, Elliot-Miller P, Ross CJ, Hayden MR. Wong E, et al. Among authors: carleton bc. Stud Health Technol Inform. 2009;143:209-14. Stud Health Technol Inform. 2009. PMID: 19380938

6

Application of principal component analysis to pharmacogenomic studies in Canada.

Visscher H, Ross CJ, Dubé MP, Brown AM, Phillips MS, Carleton BC, Hayden MR. Visscher H, et al. Among authors: carleton bc. Pharmacogenomics J. 2009 Dec;9(6):362-72. doi: 10.1038/tpj.2009.36. Epub 2009 Aug 4. Pharmacogenomics J. 2009. PMID: 19652663

7

Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy.

Ross CJ, Katzov-Eckert H, Dubé MP, Brooks B, Rassekh SR, Barhdadi A, Feroz-Zada Y, Visscher H, Brown AM, Rieder MJ, Rogers PC, Phillips MS, Carleton BC, Hayden MR; CPNDS Consortium. Ross CJ, et al. Among authors: carleton bc. Nat Genet. 2009 Dec;41(12):1345-9. doi: 10.1038/ng.478. Epub 2009 Nov 8. Nat Genet. 2009. PMID: 19898482

8

Cases: Cocaine adulterant linked to neutropenia.

Wiens MO, Son WK, Ross C, Hayden M, Carleton B. Wiens MO, et al. CMAJ. 2010 Jan 12;182(1):57-9. doi: 10.1503/cmaj.090286. Epub 2009 Dec 7. CMAJ. 2010. PMID: 19969562 Free PMC article. No abstract available.

9

The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology.

Ross CJ, Visscher H, Sistonen J, Brunham LR, Pussegoda K, Loo TT, Rieder MJ, Koren G, Carleton BC, Hayden MR; CPNDS Consortium. Ross CJ, et al. Among authors: carleton bc. Thyroid. 2010 Jul;20(7):681-7. doi: 10.1089/thy.2010.1642. Thyroid. 2010. PMID: 20578893 Review.

10

Communicating pharmacogenetic research results to breastfeeding mothers taking codeine: a pilot study of perceptions and benefits.

Madadi P, Joly Y, Avard D, Chitayat DC, Smith MA, Ross CJ, Carleton BC, Hayden MR, Koren G. Madadi P, et al. Among authors: carleton bc. Clin Pharmacol Ther. 2010 Dec;88(6):792-5. doi: 10.1038/clpt.2010.125. Epub 2010 Aug 25. Clin Pharmacol Ther. 2010. PMID: 20739920

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

272 results

Search Page

Filters